New Tests
May 2012
New tests are continually developed by the clinical and research laboratories of Mayo Clinic. These tests are subjected to an intense laboratory and clinical correlative process to ensure their diagnostic utility prior to their release.
Significant new test announcements are included with each Communiqué issue to provide both clinical and technical information in a single document.
The following tests are described in this month's Communiqué:
EGFR/61247 EGFR Gene, Mutation Analysis, 29 Mutation Panel, Tumor- Useful for: Identifying non-small cell lung cancers that may respond to EGFR-tyrosine kinase inhibitor therapies ....more>>
- Useful for: Aiding in the diagnosis of PTPN11-associated Noonan syndrome and LEOPARD syndrome ...more>>
- Useful for: Genetic testing of individuals at risk for a known PTPN11 mutation ...more>>


